|
|
|
Volumn 119, Issue 1230, 2006, Pages
|
|
PHARMAC responds on agents to prevent osteoporotic fractures.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG SCREENING;
ECONOMICS;
FEMALE;
HUMAN;
NEW ZEALAND;
NOTE;
POSTMENOPAUSE OSTEOPOROSIS;
BONE DENSITY CONSERVATION AGENTS;
COST-BENEFIT ANALYSIS;
DIPHOSPHONATES;
DRUG APPROVAL;
DRUG EVALUATION;
FEMALE;
HUMANS;
NEW ZEALAND;
OSTEOPOROSIS, POSTMENOPAUSAL;
|
|
EID: 33645217807
PISSN: None
EISSN: 11758716
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
